Rankings
▼
Calendar
FOLD (Amicus Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
Mkt Cap
$5B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$634M
Net Income (TTM)
-$27M
EPS (TTM)
-$0.09
Free Cash Flow (TTM)
$30M
Gross Margin
87.9%
Op. Margin
5.2%
Net Margin
-4.3%
FCF Margin
4.7%
P/S Ratio (TTM)
7.1x
P/E Ratio (TTM)
—
YoY Rev Growth
+20.0%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$86M
$79M
-$38M
Q2 23
$95M
$85M
-$19M
Q3 23
$104M
$94M
-$17M
Q4 23
$115M
$104M
-$4M
Q1 24
$110M
$97M
-$28M
Q2 24
$127M
$115M
$15M
Q3 24
$142M
$128M
$22M
Q4 24
$150M
$135M
$16M
Q1 25
$125M
$114M
-$8M
Q2 25
$155M
$139M
-$9M
Q3 25
$169M
$148M
$34M
Q4 25
$185M
$157M
$16M
marketcaparena.com
Revenue Breakdown
FOLD
Amicus Therapeutics, Inc.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
13.4x
—
Q2 23
12.9x
—
Q3 23
12.1x
—
Q4 23
11.3x
—
Q1 24
10.6x
—
Q2 24
9.9x
—
Q3 24
9.1x
—
Q4 24
8.5x
—
Q1 25
8.3x
—
Q2 25
7.9x
—
Q3 25
7.5x
—
Q4 25
7.1x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$18M
-$20M
Q2 23
-$16M
-$18M
Q3 23
-$38M
-$40M
Q4 23
$3M
$2M
Q1 24
-$30M
-$32M
Q2 24
$23M
$22M
Q3 24
-$23M
-$23M
Q4 24
-$4M
-$4M
Q1 25
$8M
$8M
Q2 25
-$27M
-$29M
Q3 25
$36M
$35M
Q4 25
$16M
$16M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$2M
Q2 23
$2M
Q3 23
$2M
Q4 23
$2M
Q1 24
$2M
Q2 24
$1M
Q3 24
$356K
Q4 24
$288K
Q1 25
$212K
Q2 25
$2M
Q3 25
$382K
Q4 25
$299K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+9.6%
-19.6%
Q2 23
+17.1%
-19.8%
Q3 23
+26.7%
+4.3%
Q4 23
+30.6%
-8.9%
Q1 24
+28.0%
+11.5%
Q2 24
+34.0%
-1.5%
Q3 24
+36.7%
-0.6%
Q4 24
+30.1%
+12.6%
Q1 25
+13.4%
-3.6%
Q2 25
+22.1%
+47.0%
Q3 25
+19.5%
+12.5%
Q4 25
+23.7%
+26.6%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$35M
40.4%
Q2 23
$17M
17.5%
Q3 23
$17M
16.0%
Q4 23
$0
0.0%
Q1 24
$31M
27.9%
Q2 24
$16M
12.8%
Q3 24
$19M
13.2%
Q4 24
$19M
12.8%
Q1 25
$25M
20.1%
Q2 25
$18M
11.4%
Q3 25
$18M
10.7%
Q4 25
$27M
14.4%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$41M
$74M
Q2 23
$35M
$65M
Q3 23
$41M
$66M
Q4 23
$35M
$70M
Q1 24
$28M
$88M
Q2 24
$25M
$74M
Q3 24
$26M
$75M
Q4 24
$30M
$87M
Q1 25
$28M
$92M
Q2 25
$61M
$85M
Q3 25
$23M
$90M
Q4 25
$24M
$117M
marketcaparena.com
Revenue by Geography
Non-US
United States
Quarter
Non-US
United States
Q1 23
$57M
$29M
Q2 23
$57M
$37M
Q3 23
$66M
$38M
Q4 23
$72M
$43M
Q1 24
$73M
$37M
Q2 24
$77M
$50M
Q3 24
$85M
$56M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$161M
$107M
$267M
Q2 23
$211M
$54M
$266M
Q3 23
$263M
$17M
$280M
Q4 23
$247M
$39M
$286M
Q1 24
$210M
$30M
$240M
Q2 24
$209M
$51M
$260M
Q3 24
$234M
$16M
$250M
Q4 24
$214M
$36M
$250M
Q1 25
$182M
$69M
$251M
Q2 25
$159M
$72M
$231M
Q3 25
$191M
$73M
$264M
Q4 25
$214M
$80M
$294M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
291M
+3.6%
Q2 23
293M
+0.5%
Q3 23
296M
+1.0%
Q4 23
294M
-0.7%
Q1 24
303M
+3.2%
Q2 24
304M
+0.3%
Q3 24
305M
+0.3%
Q4 24
299M
-1.9%
Q1 25
308M
+2.9%
Q2 25
308M
+0.2%
Q3 25
310M
+0.7%
Q4 25
314M
+1.3%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$13K
97
FY 15
$0
185
FY 16
$19K
263
FY 17
$114K
325
FY 18
$180K
508
FY 19
$312K
584
FY 20
$540K
483
FY 21
$616K
496
FY 22
$680K
484
FY 23
$772K
517
FY 24
$1M
499
FY 25
$16K
40K
marketcaparena.com